Time-to-Regulatory Approval is a critical KPI that reflects the efficiency of the approval process for new products or services.
It directly impacts time-to-market, operational efficiency, and overall financial health.
A shorter time frame can lead to quicker revenue generation and enhanced competitive positioning.
Organizations that excel in this metric often realize significant ROI through reduced costs and improved resource allocation.
By focusing on this KPI, executives can drive strategic alignment across departments and ensure compliance without sacrificing speed.
Ultimately, optimizing this metric fosters a data-driven decision-making culture that supports sustained growth.
Time-to-Regulatory Approval is the top priority metric in KPI Depot's Medical Devices & Diagnostics KPI group. That ranking is deliberate: for a device maker, nothing downstream matters until a product clears its regulatory pathway, so this metric leads the KPI group. Around it sit Regulatory Compliance Rate, Regulatory Submission Success Rate, and Regulatory Audit Findings, with Adverse Event Reporting Rate, Patient Safety Index, and Device Failure Rate rounding out the group.
Its balanced scorecard home is the internal process perspective. Read it as a cycle-time metric that lags the quality of your submission work while leading market entry: a clean, complete filing shortens it, and the clock it reports only closes once the agency is satisfied.
The tension to watch is speed against quality. Compressing time-to-approval by filing early or thin tends to surface later as weaker Regulatory Submission Success Rate and heavier Regulatory Audit Findings, since agencies return deficient submissions with questions that restart the clock. Regulatory Submission Success Rate is the co-metric that reconciles the two: approvals that are both fast and first-pass are the ones that actually move a product to market, rather than approvals that look quick until you count the resubmissions.
The data for this metric lives in the regulatory affairs tracking system, keyed to each submission and its milestone dates. The honest join is between the submission date and the approval date, but the definitional forks around those two points decide everything.
Settle what starts and stops the clock. Does the clock include the time a submission sits on hold while you answer agency deficiency letters, or only the agency's own review time. Does a resubmission after a rejection start a fresh clock or continue the original one. Are you measuring per submission or per product, given that one product can involve several filings across jurisdictions. Pathways differ sharply too: a clearance route, a premarket approval route, and a regional conformity route run on different timelines, so blending them into one average hides more than it shows.
Segment by regulatory pathway and jurisdiction before comparing anything. The instrumentation pitfall specific to this metric is counting only approved submissions, which drops the withdrawn and abandoned filings and flatters the reported duration. Track the full cohort of submissions, not just the ones that made it through.
Many organizations overlook the complexities of regulatory requirements, leading to unnecessary delays in approvals.
Streamlining the regulatory approval process requires a focus on efficiency and clarity.
The Medical Devices & Diagnostics KPI group builds its OKRs directly on this metric. Its lead objective, to accelerate regulatory approval and reduce time-to-market without compromising compliance, names Time-to-Regulatory Approval as a key result in its own right, paired with Regulatory Submission Success Rate so speed is never pursued alone.
Adapted as a team goal, the key result is directional: shorten the approval clock for a product family over the planning horizon while raising first-pass submission success, so the objective it ladders to is faster market entry earned through cleaner filings rather than through cut corners. Any target a team attaches to this is an illustrative goal it sets for itself, not a standard drawn from other companies.
This KPI is associated with the following categories and industries in our KPI database:
KPI Depot takes you from KPI intelligence to finished deliverable. Consultants, strategy teams, FP&A leaders, and analytics teams use it to answer the two hardest questions in performance management, what to measure and what the target should be, and then to produce the scorecard itself.
The difference is intelligence, not just data. Anyone can list metrics. Every KPI in KPI Depot carries 13 practical attributes, from formula and measurement approach to diagnostic questions, risk warnings, and Balanced Scorecard perspective, across 15 corporate functions and 153 industries. And every target you set is grounded in our database of 34,304 source-attributed benchmarks, each detailing metric value, company size, time period, industry, geography, sample size, and source. Benchmark data at this scale is otherwise the domain of research services costing thousands to hundreds of thousands of dollars per year.
When your metrics are selected, KPI Depot finishes the job: export an interactive Strategy Map, a Balanced Scorecard with formulas and tracking columns, or a CSV KPI pack, and go from research to working deliverable in hours instead of weeks.
Formerly the Flevy KPI Library, KPI Depot is trusted by teams at organizations including Accenture, EY, IBM, PepsiCo, Samsung, and Vodafone.
Got a question? Email us at [email protected].
Multiple factors can affect this KPI, including the complexity of the product, regulatory requirements, and the efficiency of internal processes. Engaging with regulatory agencies early can also play a significant role in expediting approvals.
Technology can streamline documentation and communication, reducing the likelihood of errors and misunderstandings. Project management tools and centralized databases enhance collaboration and tracking, which can significantly shorten approval timelines.
While timeframes vary by industry, a general benchmark is 6 to 12 months for most sectors. However, complex products may require longer approval times due to additional scrutiny.
Regular reviews, ideally quarterly, can help organizations identify trends and areas for improvement. Frequent monitoring allows for timely adjustments to processes and resource allocation.
Collaboration between departments, such as R&D and regulatory affairs, is crucial for ensuring that submissions meet all requirements. Improved communication can lead to faster resolution of issues and a more efficient approval process.
Yes, external consultants can provide valuable expertise and insights into regulatory processes. They can help organizations navigate complex requirements and improve submission quality, ultimately reducing approval times.
Each KPI in our knowledge base includes 13 attributes.
A clear explanation of what the KPI measures
The typical business insights we expect to gain through the tracking of this KPI
An outline of the approach or process followed to measure this KPI
The standard formula organizations use to calculate this KPI
Insights into how the KPI tends to evolve over time and what trends could indicate positive or negative performance shifts
Questions to ask to better understand your current position is for the KPI and how it can improve
Practical, actionable tips for improving the KPI, which might involve operational changes, strategic shifts, or tactical actions
Recommended charts or graphs that best represent the trends and patterns around the KPI for more effective reporting and decision-making
Potential risks or warnings signs that could indicate underlying issues that require immediate attention
Suggested tools, technologies, and software that can help in tracking and analyzing the KPI more effectively
How the KPI can be integrated with other business systems and processes for holistic strategic performance management
Explanation of how changes in the KPI can impact other KPIs and what kind of changes can be expected
NEW Mapping to a Balanced Scorecard perspective (financial, customer, internal process, learning & growth)